Trial · NCT01634360
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 0 | -0.51 | Standard Deviation 2.811 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 0 | -0.68 | Standard Deviation 2.479 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 12 | -0.91 | Standard Deviation 2.913 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 12 | -1.08 | Standard Deviation 2.907 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 24 | -1.05 | Standard Deviation 2.760 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 24 | -1.15 | Standard Deviation 2.754 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 36 | -0.76 | Standard Deviation 2.638 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 36 | -1.16 | Standard Deviation 2.959 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 52 | -0.47 | Standard Deviation 3.443 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 52 | -1.34 | Standard Deviation 2.881 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 78 | -1.31 | Standard Deviation 2.547 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 78 | -1.54 | Standard Deviation 3.106 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 104 | -1.14 | Standard Deviation 3.121 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 104 | -1.81 | Standard Deviation 3.149 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 130 | -0.65 | Standard Deviation 3.710 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 130 | -1.62 | Standard Deviation 2.953 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 156 | -1.00 | Standard Deviation 2.953 | Hours |
| Mean Change From Baseline in Total Daily OFF Time (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 156 | -1.16 | Standard Deviation 2.672 | Hours |
| Mean Change From Baseline in Total Daily ON Time (Without Dyskinesias or With Non-troublesome Dyskinesias) (Hours) During Open-label Extension Study | Perampanel (Placebo During Core Study) | Week 0 | 0.85 | Standard Deviation 2.856 | Hours |
| Mean Change From Baseline in Total Daily ON Time (Without Dyskinesias or With Non-troublesome Dyskinesias) (Hours) During Open-label Extension Study | Perampanel (Perampanel 0.5, 1, or 2 mg During Core Study) | Week 0 | 1.17 | Standard Deviation 3.562 | Hours |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01634360/results